Chefaa and Neqabty Partner to allow their Customers to Seamlessly Order all their Medicine and pharmacy Needs

Chefaa and Neqabty Partner to allow their Customers to Seamlessly Order all their Medicine and pharmacy Needs

Chefaa, an Egyptian-based healthtech startup, has announced a strategic partnership with Neqabty, a Fintech community-based solution aimed at bridging the gap between syndicates and their members by automating their services and empowering them with various payment solutions via an accessible platform.

The partnership provides NEQABTY users with a new way to order all of their medication and pharmacy needs. This will be accomplished through a technical integration of both PLATFORMS, resulting in a seamless digital experience for users.

Chefaa’s partnership with Neqabty comes just a few weeks after the Egyptian GPS-enabled pharmacy benefits platform signed a partnership agreement with Mersal, an Egyptian-based health charity that provides high-quality medical care to both Egyptian and non-Egyptian patients, to allow chronic patients to schedule, order, and refill their recurring prescriptions as well as other non-pharmaceutical products from pharmacies via its web or mobile apps.

This partnership falls within the framework of the two companies’ ongoing development, with Neqabty aiming to facilitate all transactions of different syndicates’ members through technology, and Chefaa thriving to make the lives of patients and those wishing to purchase medicines and pharmacy supplies easier through smart solutions provided by the company.

Doaa Aref, Founder, and CEO of Chefaa commented on the partnership, stating that it is part of Chefaa’s next stage plan of expanding its customized medicine services for various Egyptian syndicates.

“Our collaboration with Neqabty is part of our next stage plan to expand our customized medicine services for various Egyptian syndicates.” Chefaa has recently expanded many of its business offerings to provide more tailored services to various Egyptian users. As a result, we believe that the developments that our company has witnessed will benefit the pharmaceutical market in ways that we have never seen before.”

Both organizations have discussed future collaborations while also sharing many ideas for the development of this sector.